Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.27 (
thermolysin
)
1,894
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An interaction between extracellular regulated kinase 1 (ERK1) and
calponin
has previously been reported (Menice, Hulvershorn, Adam, Wang and Morgan (1997) J. Biol. Chem. 272 (40), 25157-25161) and has been suggested to reflect a function of
calponin
as a signalling molecule. We report in this study that
calponin
binds to both ERK1 and ERK2 under native conditions as well as in an overlay assay. Using chymotryptic fragments of
calponin
, the binding site of ERK on
calponin
was identified as the
calponin
homology (CH) domain, an N-terminal region of
calponin
found in other actin-binding proteins. ERK also bound, in a gel overlay assay, alpha-actinin, a protein with two tandem CH domains, as well as a 27 kDa
thermolysin
product of alpha-actinin containing the CH domains of alpha-actinin. The CH domain of
calponin
could compete with intact
calponin
or alpha-actinin for ERK binding. Titration of acrylodan-labelled
calponin
with ERK gave a K(a) of 6x10(6) M(-1) and titration of acrylodan-labelled
calponin
with a peptide from the alphaL16 helix of ERK gave a K(a) of 1x10(6) M(-1). Recombinant ERK was found to co-sediment with purified actin and induced a fluorescence change in pyrene-labelled F-actin (K(a)=5x10(6) M(-1)). The interaction of ERK with CH domains points to a new potential function for CH domains. The interaction of ERK with actin raises the possibility that actin may provide a scaffold for ERK signalling complexes in both muscle and non-muscle cells.
...
PMID:Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. 1054 41